Why HCG Global, LensKart, PolicyBazaar are in IvyCap Ventures’ anti-portfolio1 min read . Updated: 19 Jun 2018, 09:19 AM IST
Viability of PolicyBazaar's business model and valuations of HCG Global and LensKart made IvyCap Ventures pass on the investments, says founder Vikram Gupta
Over the last 10 years of my investing experience as a private equity and venture capital investor, I have looked at more that 10,000 investment opportunities across sectors and at different stages of investments. A typical Type-2 error is considered as an investment opportunity, wherein despite having the opportunity to invest, one decided to pass because there was a convincing argument on why one should not invest. An anti-portfolio, on the other hand, is the list of those companies, which proved you wrong on your investment rejection decision.
Select your Category